“Oracle Calls Force Majeure Already?”
Medtronic's MiniMed spin-off is a positive strategic move that supports faster earnings growth via focus on higher-margin businesses.
With Medtronic recently launching a voluntary exchange offer to spin off its diabetes business unit, MiniMed, I've been thinking about how ordinary investors might evaluate this type of corporate action.
In this case, for Mini Medtronic MiniMed, there is a 7% valuation discount that you receive as an investor as part of the spin-off process.